Relationship between serum response factor and androgen receptor in prostate cancer.

about

The prognostic utility of the transcription factor SRF in docetaxel-resistant prostate cancer: in-vitro discovery and in-vivo validation.

P2860

Q36294460-506C1024-F852-414A-ABDC-C6D074E5C97B

P2860

Relationship between serum response factor and androgen receptor in prostate cancer.

Item

http://www.wikidata.org/entity/Q38845729

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Relationship between serum response factor and androgen receptor in prostate cancer.

@en

type

Item

label

Relationship between serum response factor and androgen receptor in prostate cancer.

@en

prefLabel

Relationship between serum response factor and androgen receptor in prostate cancer.

@en

P1476

Relationship between serum response factor and androgen receptor in prostate cancer.

@en

P2093

Amanda O'Neill

http://www.w3.org/2001/XMLSchema#string

Anders Bjartell

http://www.w3.org/2001/XMLSchema#string

Aurelie Fabre

http://www.w3.org/2001/XMLSchema#string

Colm Morrissey

http://www.w3.org/2001/XMLSchema#string

Elaine W Kay

http://www.w3.org/2001/XMLSchema#string

Gillian O'Hurley

http://www.w3.org/2001/XMLSchema#string

P2860

Androgen receptor variants occur frequently in castration resistant prostate cancer metastases

Androgen induction of the androgen receptor coactivator four and a half LIM domain protein-2: evidence for a role for serum response factor in prostate cancer

The deubiquitinating enzyme USP26 is a regulator of androgen receptor signaling

RhoA as a mediator of clinically relevant androgen action in prostate cancer cells

Increased PAK6 expression in prostate cancer and identification of PAK6 associated proteins

Recruitment of the androgen receptor via serum response factor facilitates expression of a myogenic gene

Identification of a clinically relevant androgen-dependent gene signature in prostate cancer

Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone.

Androgen receptor (AR) coregulators: an overview.

Targeting continued androgen receptor signaling in prostate cancer.

P304

1704-1717

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PROS.23051

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Lan K Nguyen

William M Gallagher

Maria Prencipe

Ronald William Watson

P577

2015-08-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26250344

http://www.w3.org/2001/XMLSchema#string

P932

4579008

http://www.w3.org/2001/XMLSchema#string

Relationship between serum response factor and androgen receptor in prostate cancer.

about

P2860

P2860

Relationship between serum response factor and androgen receptor in prostate cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932